AI-Powered Drug Discovery

Building Tomorrow’s Medicines Today - Learn More

Announcements

New success on Pi3kalpha inhibitor IC50, selectivity, and culture Tests,

We have released a new paper on our Covid-19 PLPro inhibitors

Phronesis AI’s Platform “Lime Drug Design™” Beta is now available for public use.

“After reviewing Phronesis AI’s Lime Drug Design™ platform with programmer Will Spagnoli, it’s evident that their innovative AI and coding infrastructure could meaningfully accelerate pharmaceutical development, potentially improving healthcare for a large number of people”
— Gary Bradski

  • This platform represents a game winning opportunity for small and medium sized pharma companies to perform like their large and successful counterparts... ...I have conducted a firsthand evaluation of the Phronesis AI platform with a moderately difficult drug discovery project and I can recommend this technology without reservation.

    Dr. Wayne R, Danter, MD

  • Phronesis A.I. is a highly dynamic environment with an incredible momentum and the type of people you want to collaborate with... ...I am convinced that thanks to the vision, experience and instinct of the team which Rick assembled we will continue to see awe-inspiring innovations combined with robust, effective tools from Phronesis A.I

    Giulio Agnetti, PhD, FAHA

  • Your approach to identify novel binders using AI and visualize where they are binding on the protein will advance the field significantly.

    Leslie M. Thompson, PhD